Canopy Growth Corp
NASDAQ: CGC
$5.59
+$0.10 (+1.8%)
Closing Price on November 5, 2024
CGC Articles
Aphria, an analyst favorite among pot stocks, rallies after market selloff Thursday.
Published:
Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability. In the United States, high state and...
Published:
Aurora Cannabis closed its acquisition of Reliva ahead of schedule but poor results from Canopy Growth may have dinged pot stocks.
Published:
Monday's top analyst upgrades and downgrades included Amazon.com, Canopy Growth, CarMax, Chipotle Mexican Grill, Geron, Hess, Inogen, Occidental Petroleum, Snap, Teva Pharmaceutical, Vail Resorts and...
Published:
Now that May’s trading days are over, it’s time to think about June, the summer, and the second half of 2020. The recession is already seeing what economists hope are the worst readings, and the...
Published:
Canopy Growth, Canada's largest pot grower, measured by market cap, reported dismal results for its fourth fiscal quarter.
Published:
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased, and in one stock incredibly.
Published:
Canadian pot company Aphria is well positioned in the medical and recreational sectors. It has eyes on Europe but the coronavirus has stalled legalization efforts in the U.S.
Published:
Cannabis stocks have disappointed but the coronavirus lockdown might boost consumer demand.
Published:
That last year was a terrible one for marijuana stocks is indisputable. So far, 2020 has not been much kinder, with Tilray shares down by more than 50% year to date. Yet, the company said it expects...
Published:
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Published:
Here's a look at what has caused Canada's marijuana sales to increase so slowly, what impact that had on Aphria in particular, and how the pandemic will affect that company's future.
Published:
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Published:
In pandemic times, solid balance sheets have been a beacon of hope to investors, and for those wishing to get into the cannabis industry, a cash-rich company like Aphria may be that vehicle.
Published:
The March 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Published: